Lithium is frequently used as a mood stabilizer in patients with mood disorders. Lithium has a narrow therapeutic index and high toxicity. Predisposing factors for intoxication are advanced age, diet disturbances, comorbid medical conditions affecting heart, kidneys or central nervous system and polypharmacy. CASE REPORT: Here we present a case of a 74-year-old woman with a history of Parkinson's disease, hypertension and bipolar disorder. She was using quetiapine, valsartan with hydrochlorothiazide and levodopa with carbidopa. She presented with altered mental status and muscle rigidity. The patient was admitted with acute lithium intoxication after her second dose of treatment. Blood lithium level increased to 3.58 mEq/L. The woman was hospitalized in the Internal Medicine Intensive Care Unit. With hydration, her symptoms resolved and her lithium level returned to normal after 118 hours. CONCLUSIONS: Prescribing physicians and emergency room physicians should be aware of conditions which may cause a decreased threshold for intoxication.
INTRODUCTION
Lithium is often used as mood stabilizing medication in patients with mood disorders. A serum level between 0.8 miliequivalent/liter (mEq/l) and 1.2 mEq/l concentrations show that intoxication is likely. 2 Lithium has a narrow therapeutic index and high toxicity. Clinical status of patients should be closely monitored for early symptoms of intoxication even when blood levels are normal. 2 Acute intoxication may be accidental or suicidal and is characterized by gastrointestinal and cardiotoxic side effects. Neurotoxic side effects are more common in chronic toxicity. 3 We present a case of a 74-year-old woman with a history of Parkinson's disease, hypertension and bipolar disorder. Her medication included quetiapine, valsartan with hydrochlorothiazide and levodopa with carbidopa. The patient was admitted with predominant gastrointestinal and neurological symptoms of acute lithium intoxication after her second dose of treatment.
CASE REPORT
A 4 Lithium levels peak between 1 to 4 hours after oral intake. Lithium is not protein bound and slowly equilibrates in days between tissues and plasma: some patients may have lithium intoxication with normal serum lithium levels, therefore a normal lithium level does not exclude intoxication. Serum lithium levels do not always correlate with patient's symptoms, treatment choices should be decided on patient's symptomatology rather than serum lithium levels. 5 Our patient experienced intoxication symptoms after her second dose of lithium. Known predisposing factors for lithium intoxication are advanced age, diet disturbances (anorexia, diarrhea, vomiting), comorbid medical conditions affecting heart, kidneys or central nervous system. Our patient was complicated with advanced age, hypertension and Parkinson's disease which may lower the threshold for toxicity. 4 Drugs such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, nonsteroidal anti-infl ammatory drugs, diuretics, calcium antagonists and neuroleptics may increase the odds of lithium intoxication. 6 Kidneys are the major route of lithium elimination. 4 Angiotensin converting enzyme inhibitors may cause lithium intoxication by decreasing angiotensin II and aldosterone, which results in natriuresis and facilitates retention of lithium. 7 Angiotensin receptor blockers may contribute to toxicity as well, cases of lithium intoxication with various angiotensin receptor blockers (candesartan, irbesartan, valsartan and losartan) have been reported. [7] [8] [9] Our patient was using an angiotensin-receptor blocker (valsartan), a diuretic (hydrochlorothiazide) and an antipsychotic (quetiapine). As mentioned earlier, combined use of these three interacting drugs may cause a decreased threshold to intoxication.
Lithium intoxication, due to narrow therapeutic index and frequent use is a common clinical picture. Both prescribing physicians and emergency room physicians should be aware of conditions which may cause a decreased threshold for intoxication. Lithium intoxications may occur even after the fi rst dose of treatment but it is not common. This patient was evaluated as prone to intoxication (a) due to her old age, (b) due to using valsartan, hydrochlorothiazide and quetiapine and (c) due to her comorbidities affecting her heart and central nervous system: hypertension and Parkinson's disease. Physicians should be aware that patients with multiple comorbidities and interfering drug usage may suffer from acute lithium intoxication even early in their treatment.
